Home > Healthcare > Analytical Instruments > Molecular Analysis > qPCR Instruments Market

qPCR Instruments Market Share

Report ID: GMI11781
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

qPCR Instruments Market Share

The market is fragmented, with a mix of large multinational corporations and numerous small to mid-sized companies competing for market share. The key strategies driving growth in this sector include the development and introduction of innovative qPCR technologies that offer enhanced accuracy, efficiency, and cost-effectiveness. This focus on innovation is crucial for addressing the evolving needs of clinical diagnostics and research while improving patient outcomes. As companies strive to stay competitive, advancements in qPCR technology are pivotal for capturing market share and meeting the increasing demand for sophisticated diagnostic and research tools.

qPCR Instruments Market Companies

Some of the eminent market participants operating in the qPCR instruments industry include:

Abbott Laboratories
Agilent Technologies, Inc.
Azure Biosystems Inc.
Bio Molecular Systems
BIOMÉRIEUX SA
Bio-Rad Laboratories, Inc.
Danaher Corporation
Eppendorf
F. Hoffmann-La Roche Ltd.
Merck KGaA
QIAGEN N.V.
Quantabio
Siemens Healthineers AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The qPCR instruments industry was valued at approximately USD 1.6 billion in 2023 and is estimated to grow at a CAGR of 8.4% from 2024 to 2032, driven by the increasing prevalence of diseases and the rising emphasis on personalized medicine.

The qPCR systems segment recorded USD 644.2 million in 2023 and is expected to dominate the market due to their essential role in real-time PCR testing, providing a crucial platform for quantitative analysis in diagnostics, research, and drug development.

The North America qPCR instruments market recorded USD 621 million in 2023 and is anticipated to grow at a CAGR of 8.1% between 2024 and 2032, driven by the increasing incidence of infectious diseases such as HIV, influenza, and COVID-19.

Key players in the qPCR instruments industry include Abbott Laboratories, Agilent Technologies, Inc., Azure Biosystems Inc., Bio Molecular Systems, BIOM